ArticlePharmaceutics2021

Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation.

Dimitrios T Trafalis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.